Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;52(2):189-95.
doi: 10.1002/mus.24642. Epub 2015 May 14.

The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy

Affiliations

The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy

Tae Chung et al. Muscle Nerve. 2015 Aug.

Abstract

Introduction: To characterize cellular infiltrates in muscle biopsies from patients with anti-3-hydroxy-3-methyl-gulatryl-CoA reductase (HMGCR)-associated myopathy.

Methods: Biopsies from 18 anti-HMGCR myopathy and 7 control dermatomyositis patients were analyzed.

Results: CD4+ and CD8+ T-cells were scattered within the endomysium in 50% of anti-HMGCR biopsies. All anti-HMGCR biopsies included increased endomysial and/or perivascular CD163+ M2 macrophages; CD11c+ M1 macrophages were present in 18.8%. CD123+ plasmacytoid dendritic (PD) cells were observed within the endomysium and perivascular spaces in 62.5% of anti-HMGCR biopsies. Membrane attack complex was deposited on endothelial cells in 50% and on the sarcolemma of nonnecrotic muscle fibers in 85.7% of anti-HMGCR cases. Major histocompatibility complex class I antigen was up-regulated in 87.5% of the anti-HMGCR cases.

Conclusions: In addition to necrosis, scattered CD4+, CD8+, and PD cells are characteristic of anti-HMGCR myopathy. Predominant M2 polarization suggests infiltrating macrophages are more likely to be involved with tissue repair than destruction.

Keywords: anti-HMGCR myopathy; autoimmune myopathy; immune-mediated necrotizing myopathy; muscle histology; myositis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: ALM and LC-S have patented the anti-HMGCR antibody test.

Figures

Figure 1
Figure 1
Representative serial muscle biopsies sections from anti-HMGCR myopathy (A, C, E, G, I, K) and DM (B, D, F, H, J, L) patients were stained with H&E (A, B), anti-CD3 (C, D), CD4 (E, F), CD8 (G, H), CD20 (I, J), and CD68 (K, L). In the anti-HMGCR case, H&E staining reveals degeneration, necrosis, and myophagocytosis of endomysial myofibers. IHC staining shows sparse endomysial CD3, CD4, and CD8 cells with no CD20 positive cells. In anti-HMGCR myopathy, most inflammatory infiltrates are CD68-positive macrophages. In the DM case, H&E staining shows myofiber atrophy, myofiber degeneration, and inflammatory infiltrates. Inflammatory infiltrates from the DM case include numerous CD68 positive macrophages with similar numbers of CD3, CD4, and CD8 cells and a few scattered CD20 cells.
Figure 2
Figure 2
Representative serial sections from 2 typical anti-HMGCR myopathy patients (A,B and C,D) show significant staining for M2 macrophages with anti-CD163 (A,C) but no M1 macrophages staining positive for CD11c (B,D). In contrast, sections from a single patient who was later diagnosed with cholangiocarcinoma had a modestly increased number of CD11c positive M1 macrophages (F,H) in addition to large numbers of M2 macrophages which stain positively for CD163 (E,G).
Figure 3
Figure 3
Immunostaining reveals a modest number of CD123 positive plasmacytoid dendritic cell cells (arrowheads) within the endomysium of 2 different anti-HMGCR myopathy patients (A and B). Note that both inflammatory cells (arrowheads) and myonuclei are stained with anti-CD123.

References

    1. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA. 2011;305:183–190. - PMC - PubMed
    1. Mammen AL. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci. 2010;1184:134–153. - PubMed
    1. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14:337–345. - PubMed
    1. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol. 2005;57:664–678. - PubMed
    1. Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010;62:2757–2766. - PMC - PubMed

Publication types

MeSH terms

Substances